Nanosonics Limited (ASX: NAN)
Health Care · Health Care Equipment & Supplies · AU
AU$3.63
+2.25% today · -11.7% 1Y
Nanosonics Limited (ASX: NAN) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $778.41M and employs 470 people.
Over the last twelve months the share price has lost 11.7%, trading between 2.94 and 4.77.
Tweenvest scores Nanosonics Limited across four factors: quality 79/100, value 63/100, growth 73/100. Its strongest factor is quality.
NAN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $778.41M
- Revenue (TTM)
- $138.25M
- P/E
- 54.59
- EPS
- 0.07
- Dividend yield
- —
- Beta (5Y)
- 1.20
- 52-week high
- AU$4.77
- 52-week low
- AU$2.94
- Avg volume (3M)
- —
- Shares outstanding
- 299.16M
- Employees
- 470
- Next earnings
- —
About Nanosonics Limited
Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinfection system, including all related supplies and accessories. Additionally, it dedicates resources to the exploration, development, and market launch of innovative infection control, decontamination products, and their associated technologies. Key offerings from Nanosonics include trophon2, an advanced device for high-level disinfection of ultrasound probes; trophon EPR, a low-temperature, high-level disinfection method specifically for intra-cavity ultrasound probes; and Nanosonics AuditPro, a comprehensive solution for managing compliance with infection control workflows. Established in 2000, Nanosonics Limited is headquartered in Macquarie Park, Australia.
- ISIN
- AU000000NAN9
- Founded
- 2000
- Listed since
- May 17, 2007
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.88B | $115.87 | -0.69% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.97B | $370.74 | -0.76% |
| Stryker CorporationNYSE: SYK | $125.74B | $330.63 | +0.86% |
| Medtronic plcNYSE: MDT | $118.91B | $91.86 | -1.12% |
| EssilorLuxottica Société anonymeENXTPA: EL | $86.72B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $71.03B | $49.91 | +1.84% |
| Siemens Healthineers AGXTRA: SHL | $52.46B | €39.70 | -1.71% |
| HOYA CorporationTSE: 7741 | $52.35B | ¥24,895.00 | -1.37% |
Figures last refreshed Aug 18, 2026.